PATENT CLAIM ANALYSIS

Application Number: 16213732
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-03
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to the use of a compound which inhibits the activity of MKK4 as a medicament for the treatment of a patient suffering from an impaired liver function, to the use of a compound as a medicament for the treatment of liver failure, including acute/fulminant or chronic liver failure and/or for increasing the regeneration of liver tissue in a patient.

Claim (Index 7):
The cultivated hepatocyte of  claim 5 , wherein the hepatocyte is arranged in a vessel having an entry port for entry of blood of a patient and an exit port for recirculating the blood to the patient.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 98.0
- Lexical Diversity: 1.78378
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14875879', '14009738', '13693578', '12913515', '14787416']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7564172938480431
- 35 USC 102 Novelty (BERT): 0.5474744293623189
- Combined Prediction Score: 0.7355230073994707
- Mean Citation Score: 338.06523
- Max Citation Score: 573.7237
- Similarity Product: 242.3144214005113

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test